{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:59:18Z","timestamp":1769317158878,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Describe complications and clinical outcomes of heavy silicone oil (HSO) Oxane HD\u00ae use as an alternative to overcome the challenges of performing vitrectomy to treat tractional and rhegmatogenous retinal detachments with proliferative vitreoretinopathy (PVR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective, observational study was performed on patients from one center from August 2014 to Aug 2023. It was included patients who underwent surgery using HSO Oxane HD\u00ae to treat rhegmatogenous retinal detachment with PVR or mixed tractional and rhegmatogenous diabetic retinal detachment. Severely ill patients who could not attend to follow up were excluded. The primary outcome was successful retinal attachment at first postoperative month. A descriptive analysis was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 31 patients, 29 (93.5%) underwent surgeries due to rhegmatogenous retinal detachment and two (6.5%) for diabetic retinal detachment. The primary anatomic success was achieved in 27 (87.1%) patients. At the final visit, 17 (56.6%) had vision better than 20\/400 (range, 20\/30 to light perception). The vision was stable or improved in 22 (76.8%) patients at the end of follow-up. Nineteen (61.3%) patients required hypotensive eye drops after HSO use and twelve (38.7%) still required hypotensive eye drops at the final follow-up; three (9.7%) patients required additional glaucoma surgeries.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HSO is safe and useful for complex retinal detachments cases specially with inferior tears and PVR. Ocular hypertension is frequent and usually clinically controlled with hypotensive eyedrops. Close postoperatively follow-up is advised due to the ocular complications, particularly elevated intraocular pressure and emulsification.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40942-024-00548-2","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T07:02:21Z","timestamp":1712818941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Retrospective case series of high-density silicone oil (Oxane HD) in severe proliferative vitreorretinal retinal detachment patients"],"prefix":"10.1186","volume":"10","author":[{"given":"Ramon Antunes De","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius Oliveira","family":"Pesquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Zago","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murilo Ubukata","family":"Polizelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aalec Rinhel Souza Ferreira Da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilva Simeren Bueno De","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Antonio Brant","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octaviano Magalhaes","family":"Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7034-8091","authenticated-orcid":false,"given":"Mauricio","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"key":"548_CR1","doi-asserted-by":"crossref","unstructured":"Cazabon S, Hillier RJ, Wong D. Heavy silicone oil: a novel intraocular tamponade agent. Optom Vis Sci 2011;88.","DOI":"10.1097\/OPX.0b013e318216d345"},{"key":"548_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10792-015-0068-4","volume":"36","author":"IJ Dooley","year":"2016","unstructured":"Dooley IJ, Duignan ES, Kilmartin DJ. Long-term heavy silicone oil intraocular tamponade. Int Ophthalmol. 2016;36:3\u20137.","journal-title":"Int Ophthalmol"},{"key":"548_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00417-008-0806-7","volume":"246","author":"F Boscia","year":"2008","unstructured":"Boscia F, Furino C, Recchimurzo N, et al. Oxane HD vs silicone oil and scleral buckle in retinal detachment with proliferative vitreoretinopathy and inferior retinal breaks. Graefes Arch Clin Exp Ophthalmol. 2008;246:943\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"548_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1177\/112067210701700518","volume":"17","author":"N Berker","year":"2007","unstructured":"Berker N, Batman C, Ozdamar Y, et al. Long-term outcomes of heavy silicone oil tamponade for complicated retinal detachment. Eur J Ophthalmol. 2007;17:797\u2013803.","journal-title":"Eur J Ophthalmol"},{"key":"548_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1600-0420.2007.00898.x","volume":"85","author":"AM Joussen","year":"2007","unstructured":"Joussen AM, Kirchhof B, Schrage N, et al. Heavy silicone oil versus standard silicone oil as vitreous tamponade in inferior PVR (HSO Study): design issues and implications. Acta Ophthalmol Scand. 2007;85:623\u201330.","journal-title":"Acta Ophthalmol Scand"},{"key":"548_CR6","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00417-008-0876-6","volume":"246","author":"S Auriol","year":"2008","unstructured":"Auriol S, Pagot-Mathis V, Mahieu L, et al. Efficacy and safety of heavy silicone oil Densiron 68 in the treatment of complicated retinal detachment with large inferior retinectomy. Graefes Arch Clin Exp Ophthalmol. 2008;246:1383\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"548_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40942-023-00501-9","volume":"9","author":"RA De Oliveira","year":"2023","unstructured":"De Oliveira RA, De Moraes NSB, Fernandes RAB, Magalh\u00e3es O Jr, Maia M. Surgical technique for removal of high-density silicone oil (oxane HD). Int J Retina Vitreous. 2023;9(1):64.","journal-title":"Int J Retina Vitreous"},{"issue":"5","key":"548_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3928\/23258160-20190503-03","volume":"50","author":"T Caporossi","year":"2019","unstructured":"Caporossi T, Tartaro R, Finocchio L, Barca F, Giansanti F, Franco F, Rizzo S. Perfluorodecalin Versus Densiron 68 heavy silicone oil in the management of Inferior Retinal detachment recurrence. Ophthalmic Surg Lasers Imaging Retina. 2019;50(5):274\u201380.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"548_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/IAE.0b013e3181eef2fd","volume":"31","author":"A Duan","year":"2011","unstructured":"Duan A, She H, Qi Y. Complications after heavy silicone oil tamponade in complicated retinal detachment. Retina. 2011;31:547\u201352.","journal-title":"Retina"},{"key":"548_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000235926","volume":"224","author":"H Er","year":"2010","unstructured":"Er H. Primary heavy silicone oil usage in inferior rhegmatogenous retinal detachment. Ophthalmologica. 2010;224:122\u20135.","journal-title":"Ophthalmologica"},{"key":"548_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3129\/i10-107","volume":"46","author":"S Ozdek","year":"2011","unstructured":"Ozdek S, Yuksel N, Gurelik G, Hasanreisoglu B. High-density silicone oil as an intraocular tamponade in complex retinal detachments. Can J Ophthalmol. 2011;46:51\u20135.","journal-title":"Can J Ophthalmol"},{"key":"548_CR12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00417-006-0496-y","volume":"245","author":"D Sandner","year":"2007","unstructured":"Sandner D, Herbrig E, Engelmann K. High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefes Arch Clin Exp Ophthalmol. 2007;245:1097\u2013105.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"548_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5301\/ejo.5000173","volume":"23","author":"N Yesilirmak","year":"2013","unstructured":"Yesilirmak N, Pinarci EY, Akkoyun I, Yilmaz G. Adhesion of heavy silicone oil to the anterior surfaces of the posterior lens capsule. Eur J Ophthalmol. 2013;23:436\u20138.","journal-title":"Eur J Ophthalmol"},{"key":"548_CR14","doi-asserted-by":"publisher","first-page":"574825","DOI":"10.1155\/2014\/574825","volume":"2014","author":"F Morescalchi","year":"2014","unstructured":"Morescalchi F, Costagliola C, Duse S, et al. Heavy silicone oil and intraocular inflammation. Biomed Res Int. 2014;2014:574825.","journal-title":"Biomed Res Int"},{"issue":"1","key":"548_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40942-022-00413-0","volume":"8","author":"G Moussa","year":"2022","unstructured":"Moussa G, Tadros M, Ch\u2019ng SW, Sharma A, Lett KS, Mitra A, Tyagi AK, Andreatta W. Outcomes of heavy silicone oil (Densiron) compared to Silicone Oil in primary rhegmatogenous retinal detachment: a multivariable regression model. Int J Retina Vitreous. 2022;8(1):61. https:\/\/doi.org\/10.1186\/s40942-022-00413-0.","journal-title":"Int J Retina Vitreous"},{"key":"548_CR16","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1111\/aos.13830","volume":"97","author":"F Semeraro","year":"2019","unstructured":"Semeraro F, Russo A, Morescalchi F, et al. Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study. Acta Ophthalmol. 2019;97:e97\u2013102.","journal-title":"Acta Ophthalmol"},{"key":"548_CR17","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1167\/iovs.06-0941","volume":"48","author":"J Mackiewicz","year":"2007","unstructured":"Mackiewicz J, M\u00fchling B, Hiebl W, et al. In vivo retinal tolerance of various heavy silicone oils. Invest Ophthalmol Vis Sci. 2007;48:1873\u201383.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"548_CR18","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2147\/OPTH.S14252","volume":"4","author":"MR Romano","year":"2010","unstructured":"Romano MR, Angi M, Romano V, et al. Intraocular pressure changes following the use of silicone oil or Densiron 68 as endotamponade in pars plana vitrectomy. Clin Ophthalmol. 2010;4:1391\u20136.","journal-title":"Clin Ophthalmol"},{"key":"548_CR19","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/eye.2015.135","volume":"29","author":"R Moya","year":"2015","unstructured":"Moya R, Chandra A, Banerjee PJ, et al. The incidence of unexplained visual loss following removal of silicone oil. Eye. 2015;29:1477\u201382.","journal-title":"Eye"},{"issue":"1","key":"548_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40942-023-00466-9","volume":"9","author":"G Moussa","year":"2023","unstructured":"Moussa G, Tadros M, Ch\u2019ng SW, Ferrara M, Kalogeropoulos D, Sharma A, Lett KS, Mitra A, Tyagi AK, Andreatta W. Unexplained visual loss in retinal detachment repair: comparing gas, silicone oil and heavy silicone oil by multivariable regression. Int J Retina Vitreous. 2023;9(1):30. https:\/\/doi.org\/10.1186\/s40942-023-00466-9.","journal-title":"Int J Retina Vitreous"},{"key":"548_CR21","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1111\/j.1755-3768.2011.02139.x","volume":"89","author":"AM Joussen","year":"2011","unstructured":"Joussen AM, Rizzo S, Kirchhof B, et al. Heavy silicone oil versus standard silicone oil in as vitreous tamponade in inferior PVR (HSO Study): interim analysis. Acta Ophthalmol. 2011;89:e483\u20139.","journal-title":"Acta Ophthalmol"},{"key":"548_CR22","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00417-010-1358-1","volume":"248","author":"L Wickham","year":"2010","unstructured":"Wickham L, Tranos P, Hiscott P, Charteris D. The use of silicone oil-RMN3 (oxane HD) as heavier-than-water internal tamponade in complicated inferior retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol. 2010;248:1225\u201331.","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-024-00548-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-024-00548-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-024-00548-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T07:07:41Z","timestamp":1712819261000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-024-00548-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["548"],"URL":"https:\/\/doi.org\/10.1186\/s40942-024-00548-2","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,11]]},"assertion":[{"value":"22 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by local ethics committee, number 0686\/2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. The consent form was dismissed by local committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}